[_An editorial in LOZENGE AND PASTILLE._]
We hear that Nicholas Ribstone, of the Ginger Cubes Corporation, has
sold out his entire interest in the much-touted Cubes to the National
Drug Novelties Company. This comes as quite a surprise to the trade,
as no specialty in recent years had aroused so much advance interest
as the Ginger Cubes. The figure paid by National Drug Novelties for
the formula, stock in hand, and jobbing contracts already arranged, is
said to be half a million dollars. We await with interest to hear just
how Gartenbaum and his associates will develop this property. In the
meantime the affair suggests some meditations on the desirability of
guarding the medicated confectionery industry against the machinations
of mere adventurers and speculators.
(Walk, Not Run,
to Nearest Exit)
[Illustration]